Close Menu

NEW YORK (GenomeWeb News) – As the National Institutes of Health begins rolling out funding opportunities under the $10.4 billion it is receiving through the American Recovery and Reinvestment Act, the effect of these new funds is not likely to be seen until late 2009 or early 2010.

However, the extra money is expected to offset continuing weakness from other sources of funding for life sciences research, according to a report published today by Thomas Weisel Partners analyst Peter Lawson.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal reports that Russia's announcement of a coronavirus vaccine approval was met with concern as safety testing has not yet been completed.

New Scientist writes there aren't much data available on the accuracy of the two rapid COVID-19 tests the UK plans to roll out.

In PNAS this week: downstream effect of oncoprotein fusion, epigenetic changes influence tRNAs in colon cancer, and more.

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.